Mon. Oct 12th, 2026

Syngene pays Stelis Biopharma 702 crores to buy the facility. [Representational image only Credit : Unsplash/Sieuwert Otterloo] Courtesy : TH ; 05/07/202

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *